AMEX · INFU

InfuSystem Holdings, Inc.

$9.12 +$0.23 (+2.59%) 1D Market open

Key Metrics

$184.06M
Market cap
23.27×
P/E · TTM
$142.40M
Revenue · TTM
$7.91M
Net income
EPS · TTM $0.37
Dividend yield
Free cash flow $23.01M
Beta · 1Y 1.11
EBITDA · TTM $24.13M
Gross margin 56.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved -11.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Feb 24
    The stock moved +13.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$184.06M
Enterprise value$201.60M
Shares outstanding20.2M
52-wk range$5.43 – $11.04
Avg volume · 20D104.7K
Net cash −$17.54M
Book value / share$2.78
IndustrySurgical & Medical Instruments & Apparatus
ExchangeAMEX
About InfuSystem Holdings, Inc.
IPO dateDec 22, 1992
Employees473

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E23.27
P/S1.29
P/FCF8.00
EV/EBITDA8.35
EV/Sales1.42
Graham №$4.84

Profitability

Gross 56.7%
Operating 8.3%
Net 5.6%
FCF 16.2%
ROE / ROIC 13.6% · 10.4%

Financial Health

Current ratio2.14
Quick ratio1.80
Debt / equity0.33
Debt / EBITDA 0.81Low leverage
Net cash −$17.54M
Working capital$19.52M

Cash Flow · TTM

Operating CF $23.60M
Capex −$586.00K
Free cash flow $23.01M
Buybacks $7.78M
Dividends paid
Shareholder yield 4.2%

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

4.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$4.84 vs $9.12
Trades 1.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings